Invention Grant
- Patent Title: Estrogen antagonists as treatments for sclerosing disorders
-
Application No.: US14518213Application Date: 2014-10-20
-
Publication No.: US09655869B2Publication Date: 2017-05-23
- Inventor: Carol A. Feghali-Bostwick , Pamela Anne Hershberger
- Applicant: University of Pittsburgh—Of The Commonwealth System Of Higher Education
- Applicant Address: US PA Pittsburgh
- Assignee: UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
- Current Assignee: UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
- Current Assignee Address: US PA Pittsburgh
- Agency: Baker Botts L.L.P.
- Main IPC: A61K31/661
- IPC: A61K31/661 ; A61K31/566 ; A61K31/453 ; A61K31/4535 ; A61K31/4453 ; A61K31/4025 ; A61K31/216 ; A61K31/138 ; A61K31/10 ; A61K31/085 ; A61K31/57 ; A61K31/06 ; A61K31/565 ; A61K45/06
Abstract:
The present invention relates to methods and compositions for treating a subject suffering from a sclerosing disorder, comprising administering, to the subject, an effective amount of an estrogen receptor antagonist (“ERANT”), wherein said ERANT has essentially no estrogen receptor agonist activity under physiologic conditions.
Public/Granted literature
- US20150038468A1 ESTROGEN ANTAGONISTS AS TREATMENTS FOR SCLEROSING DISORDERS Public/Granted day:2015-02-05
Information query
